FOR IMMEDIATE RELEASE:

SOS STAFFING SELECTS RAPID DRUG SCREEN
American Bio Medica Corporation Secures More Employment Screening Business

KINDERHOOK, NY -- September 19, 2024 -- American Bio Medica Corporation (NASDAQ: ABMC) today announced that it will supply drug testing products to SOS Staffing Services, Inc., one of the nation's leading providers of temporary staffing services.

SOS Staffing Services will use ABMC's Rapid Drug Screen™ five-panel assays to conduct on-site drug testing of prospective temporary employees.

According to SOS Staffing, Rapid Drug Screen will facilitate reliable, on-site pre-employment drug screenings, which, in turn, helps SOS meet the needs of its clients by placing qualified candidates quickly.

"Rapid Drug Screen enables us to place qualified, drug-free candidates on the job in a matter of hours, rather than days,'' said Mark Marshall, SOS Staffing director of risk management. ``We think we have a reliable solution in hand that helps us provide value to our customers."

According to ABMC chairman and chief executive officer Robert L. Aromando Jr., the agreement represents between $70,000 and $75,000 in new annual business to ABMC, with payments beginning in the company's second (current) fiscal quarter.

"We're pleased by the in-roads ABMC has made in the workplace testing market within the past few weeks," said Aromando. "We are happy to work with a leading company like SOS Staffing, and are encouraged that companies with strategic interests in on-site drug testing acknowledge the performance and value of our products and people."

SOS Staffing Services, Inc. (NASDAQ: SOSS), with its subsidiaries and divisions, is a provider of commercial and information technology staffing and employment-related services, operating through a network of approximately 130 offices in 17 states, with employees working in 43 states. SOS Staffing is headquartered in Salt Lake City, Utah.

About American Bio Medica Corporation

American Bio Medica Corporation develops, manufactures and markets inexpensive, accurate on-site drugs-of-abuse diagnostic kits, sprays and support services worldwide. The company's global distributors target the workplace, physicians, corrections, clinical and educational markets. ABMC's Drug Detector™ identifies minute traces of illegal drugs on surfaces, while the company's Rapid Drug Screen tests individuals and is proven to correlate greater than 99% with the standard laboratory screening test.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risk and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, intellectual property rights and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.


Contact:
     American Bio Medica Corporation
     Melissa Decker, 800-227-1243, Fax: 518/758-8171
     melissa@americanbiomedica.com
     Web: www.americanbiomedica.com